Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
Is Gardasil vaccination reliable? I've heard plenty of ugly things about this vaccination. I have a 17-year-old daughter and her doctor recommends that she get this vaccine. I am very confused because of the negative and positive information. Would you be able to clarify?
Genital human papillomavirus, or HPV, which infects the skin and mucous membranes, is the most common sexually transmitted disease. About 20 million Americans have the virus, according to the Centers for Disease Control and Prevention. HPV is the major cause of cervical cancer, which kills about 250,000 women worldwide each year. In the United States, cervical cancer will be diagnosed in about 12,000 women this year, and 4,000 will die, the CDC says. Women get Pap smears to detect cervical cancer and now have the option of preventing it with a vaccine. Gardasil, developed by Merck, works to protect against four strains of HPV, including two connected to 70 percent of cervical cancers.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday
The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Boys may soon be able to get Gardasil, the vaccine given to girls and young women to prevent infection by four types of human papillomavirus.
One in four American girls ages 13 to 17 have been given at least one shot of Gardasil, the human papillomavirus vaccine that is heavily marketed as a way to prevent cervical cancer.
When Raffi Darrow brought in her two daughters, Wendy and Alice, for their annual back-to-school checkups this week, for the first time in her career as a mom, Darrow decided to be a rebel.
Is Gardasil vaccination reliable? I've heard plenty of ugly things about this vaccination. I have a 17-year-old daughter and her doctor recommends that she get this vaccine. I am very confused because of the negative and positive information. Would you be able to clarify?
Genital human papillomavirus, or HPV, which infects the skin and mucous membranes, is the most common sexually transmitted disease. About 20 million Americans have the virus, according to the Centers for Disease Control and Prevention. HPV is the major cause of cervical cancer, which kills about 250,000 women worldwide each year. In the United States, cervical cancer will be diagnosed in about 12,000 women this year, and 4,000 will die, the CDC says. Women get Pap smears to detect cervical cancer and now have the option of preventing it with a vaccine. Gardasil, developed by Merck, works to protect against four strains of HPV, including two connected to 70 percent of cervical cancers.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday.
About one in four teen girls last year got the groundbreaking vaccine that prevents cervical cancer, federal health officials reported Thursday
The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
What we said In "Merck Is on the Mend" (Feb. 5), we recommended a second look at the pharma giant, which was recovering from the low it reached in 2004 amid the Vioxx debacle. We mentioned that Merck was winning approvals for a host of new drugs, including cervical-cancer vaccine Gardasil. We cited Bear Stearns analyst John Boris's year-end price target of $53.
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
Men should be vaccinated against a sexually transmitted wart virus to protect them against a type of mouth and throat cancer, U.S. researchers said Monday.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
GlaxoSmithKline announced the results of the biggest-ever study of a cancer vaccine Wednesday, in the hopes of bolstering the competitive strength of its Cervarix against Merck's Gardasil.
The drugmakers Merck, Schering-Plough and Wyeth all reported strong first-quarter earnings - with Schering and Wyeth trouncing forecasts - but investor reaction was mixed.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
GlaxoSmithKline is getting closer to launching its challenge against Merck's monopoly on cervical cancer vaccines.
The British drugmaker GlaxoSmithKline fired a shot over Merck's bow on Thursday, by launching a study comparing its own experimental vaccine for cervical cancer to Merck's Gardasil.
On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.
Now doctors have their own online community, where they discuss everything from the latest medical break-throughs to potentially faulty drugs.
To quote Frank Sinatra, Big Pharma stocks are having "a very good year."
Big Pharma is feeling the squeeze as name-brand drugs go off patent, which is why analysts are expecting a flat or modest second quarter for most of the biggest U.S. drug makers.
The U.S. Food and Drug Administration on Thursday approved the first vaccine for cervical cancer -- Gardasil, manufactured by Merck and Co.
Federal regulators approved Gardasil, the first vaccine meant to prevent cervical cancer, the drugmaker Merck said Thursday.
Vital protection against cervical cancer could soon be made available, not just from Merck but also from GlaxoSmithKline, providing life-saving potential for women while feeding a competitive atmosphere for the drug giants.
Merck has already angered Christian conservatives by pushing to make its yet-to-be approved cervical cancer vaccine, Gardasil, mandatory for girls as young as nine. But that could be the least of the company's worries regarding the projected $4 billion-a-year vaccine.
The FDA has approved Zostavax, a new vaccine from Merck that prevents shingles, for patients 60 or older.
An FDA advisory committee recommended for approval Merck's experimental cervical cancer vaccine Gardasil, said Merck and the agency.
Merck needs a hit, and it just might be on the verge of getting one, thanks to some delicate footwork with the religious right.
JUDGING BY THE HEADLINES, IT WOULD BE EASY TO THINK that Big Pharma is on the brink of collapse. In 2006 the industry is poised to lose more than $23 billion in sales to generic competitors, its wo...
Merck's big problem in 2006 isn't just Vioxx. It's Zocor.
Judging by the headlines, it would be easy to think that Big Pharma is on the brink of collapse.
Merck, the second-biggest American drug maker, said on Friday that its experimental cervical cancer vaccine Gardasil can also prevent external genital lesions in women, including vaginal and vulvar lesions.
Drugmakers are pouring billions of dollars into research and development in their quest for the next blockbusters, and analysts have a hard time gauging whether the heavy costs will pay off.
A cervical cancer vaccine that analysts are calling the biggest potential blockbuster in Merck & Co.'s pipeline passed the first phase in late-stage testing and will be filed with the Food and Drug Administration this year, the company said Thursday.
| Most Viewed | Most Emailed | Top Searches |
© 2009 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.
